The Access and Delivery Partnership, funded by the Government of Japan, is a five-year project that aims to help LMICs enhance their capacity to access and introduce new health technologies for TB, malaria and NTDs. New health technologies are broadly defined as drugs, diagnostic tools and vaccines that are relevant for the prevention, treatment or cure of TB, malaria and NTDs, but are not yet available for market introduction or have not been introduced in LMICs.

The introduction of new health technologies can place a weighty burden on existing health systems. These burdens may include new requirements for drug regulation, supply and distribution, and health personnel training. Accordingly, the Access and Delivery Partnership will focus on providing LMIC stakeholders with the necessary skills to develop the systems and processes required to effectively access new health technologies, and introduce them to populations in need.

Led and coordinated by UNDP, the Access and Delivery Partnership is a unique collaboration among UNDP, the Special Programme for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR) and PATH. Working together, the partners will leverage the expertise within each organization to provide the full range of technical skills necessary to strengthen capacity in LMICs.